Again, all TLR3/7/9-deficient mice and WT mice developed tumours during the initial 1–2 weeks post injection (depending on the cell line used), but only Tlr triple KO mice rejected tumours within 40 days (Supplementary Fig. 2). Here, TLR3 is linked to neoplasm.